专利检索 ap:("GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED") AND inv:"Ting Yang" 第 1 页

1.

发明授权
1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors 有权

公开(公告)号：US10336719B2

公开(公告)日：2019-07-02

申请号：US16129867

申请日：2018-09-13

申请人： GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED

发明人： Weichun Chen , Ebere F Igboko , Xichen Lin , Hongfu Lu , Feng Ren , Paul Bryan Wren , Zhongmiao Xu , Ting Yang , Lindong Zhu

IPC分类号： C07D307/18 , C07D241/04 , C07D309/08 , C07C317/50 , C07C317/42 , C07C311/47 , C07D305/06 , C07D213/34 , C07D295/135 , C07D211/54 , C07D207/10 , C07D487/04 , C07D471/04 , C07D239/26 , C07D233/64

摘要： The invention relates to 1-(3-sulfonylphenyl)-3-(cyclopent-2-en-1-yl)urea derivatives, and their use in treating or preventing diseases and conditions mediated by the CXCR2 receptor. In addition, the invention relates to compositions containing the derivatives and processes for their preparation.

2.

发明申请
Novel Compounds 审中-公开

公开(公告)号：US20190010135A1

公开(公告)日：2019-01-10

申请号：US16129867

申请日：2018-09-13

申请人： GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED

发明人： Weichun Chen , Ebere F. Igboko , Xichen Lin , Hongfu Lu , Feng Ren , Paul Bryan Wren , Zhongmiao Xu , Ting Yang , Lindong Zhu

IPC分类号： C07D307/18 , C07D241/04 , C07D309/08 , C07C317/50 , C07C317/42 , C07C311/47 , C07D305/06 , C07D213/34 , C07D295/135 , C07D211/54 , C07D207/10 , C07D487/04 , C07D471/04 , C07D239/26 , C07D233/64

CPC分类号： C07D307/18 , C07C311/47 , C07C317/42 , C07C317/50 , C07C2601/04 , C07C2601/08 , C07C2601/10 , C07C2601/14 , C07D207/10 , C07D211/54 , C07D213/34 , C07D233/64 , C07D239/26 , C07D241/04 , C07D295/135 , C07D305/06 , C07D309/08 , C07D471/04 , C07D487/04

摘要： The invention relates to 1-(3-sulfonylphenyl)-3-(cyclopent-2-en-1-yl)urea derivatives, and their use in treating or preventing diseases and conditions mediated by the CXCR2 receptor. In addition, the invention relates to compositions containing the derivatives and processes for their preparation.

3.

发明授权
1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors 有权

公开(公告)号：US10106515B2

公开(公告)日：2018-10-23

申请号：US15314124

申请日：2015-05-27

申请人： GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED

发明人： Weichun Chen , Ebere F Igboko , Xichen Lin , Hongfu Lu , Feng Ren , Paul Bryan Wren , Zhongmiao Xu , Ting Yang , Lingdong Zhu

IPC分类号： C07D307/18 , C07D241/04

摘要： The invention relates to 1-(3-sulfonylphenyl)-3-(cyclopent-2-en-1-yl)urea derivatives, and their use in treating or preventing diseases and conditions mediated by the CXCR2 receptor In addition, the invention relates to compositions containing the derivatives and processes for their preparation.